鳖甲煎丸缓解氧化三甲胺加重的BDL大鼠肝纤维化的分子机制OA
Molecular mechanism of Biejiajian pills in alleviating trimethylamine oxide-aggravated liver fibrosis in BDL rats
目的 建立鳖甲煎丸(BJJP)对胆总管结扎(BDL)诱导的大鼠肝纤维化的治疗作用模型,并研究BJJP缓解氧化三甲胺(TMAO)加重的BDL大鼠肝纤维化分子机制.方法 为建立BJJP改善BDL大鼠肝纤维化模型,30只SD大鼠被随机分为假手术(Sham)组、胆总管结扎(BDL)组、鳖甲煎丸低(BJJP-L)、中(BJJP-M)、高(BJJP-H)剂量组,利用Masson和Sirius Red染色分析分析胶原纤维的沉积情况,免疫组织化学染色(IHC)和Western blot实验检测大鼠肝脏组织中α-平滑肌肌动蛋白(α-SMA)及Ⅰ型胶原α1链(COL1A1)的表达水平;对Sham、BDL、BJJP-H组大鼠粪便进行16S rRNA高通量菌群测序;三甲胺(TMA)非靶向代谢组学及TMAO靶向代谢组学技术分别检测Sham、BDL、BJJP-H组大鼠粪便中TMA及血清中TMAO含量.为检测BJJP对TMAO加重的肝纤维化的治疗作用及可能分子机制,将20只SD大鼠随机分为假手术(Sham)组、胆总管结扎(BDL)组、BDL+TMAO 组、BDL+TMAO+BJJP-H 组,通过 HE、Masson 及 Sirius Red 染色观察各组大鼠肝脏组织形态学改变;应用Western blot定量分析各组α-SMA、黄素单氧化酶3(FMO3)、磷酸化(p-)的蛋白激酶B(AKT)、磷酸化(p-)的磷脂酰肌醇激酶3(PI3K)的表达水平.结果 BDL组大鼠肝脏组织较Sham组胶原纤维、α-SMA蛋白、COL1A1蛋白的表达水平均升高(P<0.000 1,P<0.000 1,P<0.001);与BDL 组相比,BJJP-L、BJJP-M、BJJP-H 组中大鼠的胶原纤维明显减少(P<0.05,P<0.05,P<0.001),α-SMA 蛋白、COL1A1蛋白的表达水平显著降低(均P<0.05).BJJP能够改善BDL大鼠肠道菌群及菌群代谢紊乱,降低粪便中TMA含量,降低血清中TMAO水平(均P<0.05).相比于Sham组,BDL组大鼠肝细胞排列紊乱,可见明显肿胀的肝细胞及大量胶原纤维组织,α-SMA、FMO3、p-AKT、p-PI3K蛋白表达增加(均P<0.05);相比于BDL组,BDL+TMAO组大鼠肝组织中的上述指标进一步增加(P<0.001,P<0.05,P<0.000 1,P<0.05);相比于BDL+TMAO组,BDL+TMAO+BJJP-H组大鼠肝细胞排列层次较齐,胶原纤维沉积减少(P<0.000 1),α-SMA、FMO3、p-AKT、p-PI3K 蛋白表达减少(P<0.001,P<0.01,P<0.001,P<0.05).结论 BJJP 能够改善BDL大鼠的肝纤维化,TMAO加重BDL大鼠的肝纤维化,BJJP可能通过调节肠道菌群TMAO缓解BDL大鼠的肝纤维化进程.
Objective To establish a model to evaluate the therapeutic effect of Biejiajian pills(BJJP)on bile duct ligation(BDL)-induced liver fibrosis in rats,and to investigate the molecular mechanisms by which BJJP alleviates trimethlylamine oxide(TMAO)-aggravated liver fibrosis in BDL rats.Methods A rat model of therapeutic BJJP for BDL-induced hepatic fibrosis was established.Thirty rats were divided randomly into Sham,BDL,and BJJP low-dose(-L),medium-dose(-M),and high-dose(-H)groups.Collagen-fiber deposition was analyzed by Masson and Sirius Red staining.Expression levels of α-smooth muscle actin(α-SMA)and type Ⅰ collagen α1 chain(COL1A1)proteins in liver tissue in each group were detected by immunohistochemical staining and Western blot.Feces were collected from rats in the Sham,BDL,the BJJP-H groups for 16S rRNA high-throughput microbial sequencing and non-targeted metabolomics analysis.Serum and feces levels of trimethylamine(TMA)and TMAO were determined in the Sham,BDL,and BJJP-H groups,respectively,by non-targeted and targeted metabolomics technologies.To investigate the therapeutic effects of BJJP on TMAO-aggravated hepatic fibrosis and its potential molecular mechanisms,a further 20 Sprague Dawley rats were divided randomly into Sham,BDL,BDL+TMAO,and BDL+TMAO+BJJP-H groups.Changes in histomorphology and collagen fibers in liver tissue were detected by hematoxylin-eosin,Masson,and Sirius Red staining.Expression levels of α-SMA,flavin-containing monooxygenase 3(FMO3),phosphorylated(p-)protein kinase B(AKT),and p-phosphatidylinositol 3-kinase(PI3K)in each group were analyzed quantitatively by Western blot.Results Compared with the Sham group,liver levels of collagen fiber,α-SMA and COL1A1 protein were increased in the BDL group(P<0.000 1,P<0.000 1,P<0.001).Compared with the BDL group,levels of collagen fiber in the BJJP-L,BJJP-M,and BJJP-H groups were significantly decreased(P<0.05,P<0.05,P<0.001),as well as the levels of α-SMA protein and COL1A1 protein(all P<0.05).BJJP improved the intestinal flora and metabolic disorders in BDL rats,and reduced feces levels of TMA and serum levels of TMAO(all P<0.05).Compared with the Sham group,rats in the BDL group exhibited disorganized hepatic cord arrangement,evident hepatocyte swelling,and extensive collagen-fiber deposition,along with up-regulation of α-SMA,FMO3,p-AKT,and p-PI3K protein expression(all P<0.05).The above indicators in liver tissues of rats were further increased in the BDL+TMAO group compared with the BDL group(P<0.001,P<0.05,P<0.000 1,P<0.05).Compared with the BDL+TMAO group,rats in the BDL+TMAO+BJJP-H group exhibited more orderly hepatocellular arrangement,reduced collagen-fiber deposition(P<0.000 1),and decreased protein expression of α-SMA,FMO3,p-AKT,and p-PI3K(P<0.001,P<0.01,P<0.001,P<0.05).Conclusions BJJP can improve hepatic fibrosis while TMAO can aggravate hepatic fibrosis in BDL rats.BJJP may alleviate the hepatic fibrosis process in BDL rats by regulating intestinal flora TMAO.
于笑涵;杨定卓;高永旭;刘秦瑜欣;崔笑妍;张荣花;章广玲;刘志勇
华北理工大学临床医学院,河北省医工融合精准医疗重点实验室,河北唐山 063000华北理工大学临床医学院,河北省医工融合精准医疗重点实验室,河北唐山 063000华北理工大学基础医学院,河北省慢性疾病重点实验室,河北唐山 063210华北理工大学临床医学院,河北省医工融合精准医疗重点实验室,河北唐山 063000华北理工大学基础医学院,河北省慢性疾病重点实验室,河北唐山 063210华北理工大学基础医学院,河北省慢性疾病重点实验室,河北唐山 063210华北理工大学临床医学院,河北省医工融合精准医疗重点实验室,河北唐山 063000华北理工大学临床医学院,河北省医工融合精准医疗重点实验室,河北唐山 063000
医药卫生
鳖甲煎丸肝纤维化胆总管结扎氧化三甲胺
Biejiajian pillshepatic fibrosisbile duct ligationtrimethlylamine oxide
《中国比较医学杂志》 2026 (7)
27-39,13
河北省自然科学基金(H2023209047,H2024209077)河北省中央引导地方科技发展资金项目(246Z7720G).
评论